Regulation of self-tolerance by CD80/CD86 interactions

Current Opinion in Immunology

Volumn 9, Issue 6, 1997, Pages 858-862

  Lu, Pin ^a   Wang, Yue Lynn ^b   Linsley, Peter S ^a  

^a BRISTOL MYERS SQUIBB   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN;

ANTIGEN PRESENTATION; AUTOIMMUNE DISEASE; CELLULAR IMMUNITY; CLONAL ANERGY; DISEASE COURSE; HELPER CELL; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; KNOCKOUT MOUSE; NONHUMAN; SHORT SURVEY; T LYMPHOCYTE ACTIVATION;

EID: 0031446765     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(97)80190-2     Document Type: Article

References (34)

1. Kruisbeek AM, Amsen D: Mechanisms underlying T cell tolerance. Curr Opin Immunol 1996, 8:233-244.
2. Sprent J, Webb SR: Intrathymic and extrathymic deletion of T cells. Curr Opin Immunol 1995, 7:196-205.
3. Miller JFAP, Basten A: Mechanism of tolerance to self. Curr Opin • Immunol 1996, 8:815-821. In this review the concepts of immune tolerance are comprehensively discussed, such as intrathymic and peripheral tolerance, as well as the etiology of autoimmune diseases. Th2-response-associated tolerance are also discussed.
4. Ridge JP, Fuchs EJ, Matzinger P: Neonatal tolerance revisited: •• turning on newborn T cells with dendritic cells. Science 1996, 271:1723-1726. This study examined the CTL response of neonatal T cells to antigens presented by either nonprofessional or professional APCs. Neonatal T cells were equally responsive as adult T cells to antigens presented by professional APCs. On the other hand, neither neonatal or adult T cells responded to antigens presented by nonprofessional APCs. Therefore, the immune response of neonatal T cells are regulated by the functional properties of APCs, not by self-nonself discrimination.
5. Forsthuber T, Yip HC, Lehmann PV: Induction of TH1 and TH2 •• immunity in neonatal mice. Science 1996, 271:1728-1730. Neonatal T cells were immunized with antigens and their primary and secondary proliferative responses were examined and compared with the responses of adult T cells. Results showed that neonatal T cells were fully competent to secrete cytokines and help to generate antibody responses to antigen stimulation. As in adult T cells, the outcome of the neonatal T-cell responses was determined by the type of adjuvant. Antigens immunized with incomplete Freund's adjuvant induced a similar scale of Th2 responses while immunization with complete Freund's adjuvant resulted in Th1 responses in both neonates and adult mice. Thus, neonatal T cells were not specially susceptible to tolerance induction.
6. Lenschow DJ, Walunas TL, Bluestone JA: CD28/B7 system of T •• cell costimulation. Annu Rev Immunol 1996,14:233-258. This is a recent review about the biological functions of CD28/CTLA-4 (CD152) and CD80/CD86 costimulatory systems. It gives detailed discussions of the putative roles of the costimulatory system in general T-cetl activation, transplantation, humoral responses and autoimmune responses. The differential effects of CD80 and CD86 were also thoroughly discussed. Finally, a 'strength-of-signal' model for CD28-CD80/CD86 costimulation was proposed to explain the differential effects.
7. June CH, Bluestone JA, Nadler LM, Thompson CB. The B7 and CD28 receptor families. Immunol Today 1994, 15:321-331.
8. Inaba K, Inaba M, Witmer-Pack M, Hatchcock K, Hodes R, Steinman RM: Expression of B7 costimulator molecules on mouse dendritic cells. Adv Exp Med Biol 1995, 378:65-70.
9. Inaba K, Witmer-Pack M, Inaba M, Hathcock KS, Sakuta H, Azuma M, Yagita H, Okumura K, Linsley PS, Ikehara S, et al.: The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J Exp Med 1994, 180:1849-1860.
10. Hathcock KS, Laszlo G, Pucillo C, Linsley P, Hodes RJ: Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function. J Exp Med 1994, 180:631-640.
11. Roth R, Nakamura T, Mamula MJ: B7 costimulation and autoantigen specificity enable B cells to activate autoreactive T cells. J Immunol 1996, 157:2924-2931.
12. Khoury SJ, Akalin E, Chandraker A, Turka LA, Linsley PS, Sayegh MH, Hancock WW: CD28-B7 costimulatory blockade by CTLA4lg prevents actively induced experimental autoimmune encephalomyelitis and inhibits Th1 but spares Th2 cytokines in the central nervous system. J Immunol 1995, 155:4521-4524.
13. Charlton B, Auchincloss HJ, Fathman CG: Mechanisms of transplantation tolerance, Annu Rev Immunol 1994, 12:707-734.
14. Onodera K, Hancock WW, Graser E, Lehmann M, Sayegh MH, •• Strom TB, Volk HD, Kupiec-Weglinski JW: Type 2 helper T cell-type cytokines and the development of 'infectious' tolerance in rat cardiac allograft recipients. J Immunol 1997,158:1572-1581. Non-depleting anti-CD4 mAb treatment blocked cardiac allograft rejection in LEW rats. Moreover, T cells isolated from these animals were able to transfer the graft tolerance to recipients. These T cells showed significantly diminished Th1 cytokine production but greatly enhanced Th2 cytokine production. Inhibition of Th2 cytokine production abrogated tolerance transfer capacities of these T cells.
15. Onodera K, Lehmann M, Akalin E, Volk HD, Sayegh MH, Kupiec-Weglinski JW: Induction of "infectious" tolerance to MHC-incompatible cardiac allografts in CD4 monoclonal antibody-treated sensitized rat recipients. J Immunol 1996, 157:1944-1950.
16. Miller SD, Vanderlugt CL, Lenschow DJ, Pope JG, Karandikar NJ, Dal Canto MC, Bluestone JA: Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE Immunity 1995, 3:739-745.
17. Saito K, Yagita H, Hashimoto H, Okumura K, Azuma M: Effect of • CD80 and CD86 blockade and anti-interleukin-12 treatment on mouse acute graft-versus-host disease. Eur J Immunol 1996, 26:3098-3106. The combination of anti-CD80 and anti-CD86 mAb blocked acute graft-versus-host-disease (GVHD) in a murine model, while blocking either CD80 or CD86 alone had no effect. GVDH blockade was associated with reduced production of IFN-γ, but the production of IL-4 and IL-10 was not affected.
18. Matzinger P: Tolerance, danger, and the extended family. Annu Rev Immunol 1994,12:991-1045.
19. Gill RG, Coulombe M, Lafferty KJ: Pancreatic islet allograft immunity and tolerance: the two-signal hypothesis revisited. Immunol Rev 1996, 149:75-96.
20. Tivol EA; Schweitzer AN; Sharps AH: Costimulation and autoimmunity. Curr Opin Immunol 1996, 8:822-830.
21. Nicholson LB, Kuchroo VK: Manipulation of the Th1/Th2 balance in autoimmune disease. Curr Opin Immunol 1996, 8:837-842.
22. Finck BK, Linsley PS, Wofsy D: Treatment of murine lupus with CTLA4lg. Science 1994, 265:1225-1227
23. Lenschow DJ, Ho SC, Sattar H, Rhee L, Gray G, Nabavi N, Herold KC, Bluestone JA: Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J Exp Med 1995, 181:1145-1155.
24. Kuchroo VK, Das MP, Brown JA, Ranger AM, Zamvil SS, Sobel RA, Weiner HL, Nabavi N, Glimcher LH: B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 1995, 80:707-718.
25. Racke MK, Scott DE, Quigley L, Gray GS, Abe R, June CH, Perrin PJ: Distinct roles for B7-1 (CD-80) and B7-2 (CD-86) in the initiation of experimental allergic encephalomyelitis. J Clin Invest 1995, 96:2195-2203.
26. Larsen CP, Elwood ET, Alexander DZ, Ritchie SC, Hendrix R, •• Tucker-Burden C, Cho HR, Aruffo A, Hollenbaugh D, Linsley PS et al.: Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996, 381:434-438. This study showed that simultaneous blockade of CD80/CD86 and CD154 (CD40) signaling effectively abrogated T-cell responses and induced long-term acceptance of cardiac and skin allografts survival. Blocking CD80/CD86 or CD154 (CD40) alone only partially reduced T-cell responses and the allografts were ultimately rejected. These data indicate that tolerance is more likely be induced by the combined blockade of CD80/CD96 and CD154 (CD40).
27. Webb LM, Walmsley MJ, Feldmann M: Prevention and • amelioration of collagen-induced arthritis by blockade of the CD28 co-stimulatory pathway: requirement for both B7-1 and B7-2. Eur J Immunol 1996, 26:2320-2328. Neither anti-CD80 nor anti-CD86 mAb treatment alone affected the course of collagen-induced arthritis. Blocking both CD80 and CD86 was required for disease inhibition.
28. Nakajima A, Azuma M, Kodera S, Nuriya S, Terashi A, Abe M, Hirose S, Shirai T, Yagita H, Okumura K: Preferential dependence of autoantibody production in murine lupus on CD86 costimulatory molecule. Eur J Immunol 1995, 25:3060-3069.
29. Perrin PJ, Scott D, Davis TA, Gray GS, Doggett MJ, Abe R, •• June CH, Racke MK: Opposing effects of CTLA4-lg and anti-CD80 (B7-1) plus anti-CD86 (B7-2) on experimental allergic encephalomyelitis. J Neuroimmunol 1996, 65:31-39. In this study, EAE mice treated with CTLA4-lg showed delated disease onset and reduced severity. Anti-CD86 mAb treatment blocked the first episode of EAE but was ineffective in preventing subsequent disease relapses. Surprisingly, combined treatment of anti-CD80 and anti-CD86 mAbs exacerbated the disease.
30. Stephens LA, Kay TW: Pancreatic expression of B7 costimulatory molecules in the non-obese diabetic mouse. Int Immunol 1995, 7:1885-1895.
31. Tsokos GC: Lymphocytes, cytokines, inflammation, and immune trafficking. Curr Opin Rheumatol 1995, 7:376-383.
32. Imagawa A, Hanafusa T, Itoh N, Miyagawa J, Nakajima H, Namba M, Kuwajima M, Tamura S, Kawata S, Matsuzawa Y, Harlan DM: Islet-infiltrating T lymphocytes in insulin-dependent diabetic patients express C080 (B7-1) and CD86 (B7-2). J Autoimmun 1996, 9:391-396.
33. Borriello F, Sethna MP, Boyd SD, Schweitzer AN, Tivol EA, Jacoby •• D, Strom TB, Simpson EM, Freeman GJ, Sharpe AH: B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity 1997, 6:303-313. The humoral immune responses of CD80 and CD86 single-gene knockout and CD80/CD86 double knockout mice were investigated. CD80 knockout mice showed similar antibody responses to wild-type mice, but CD86 knockout mice had more defects in antibody production when immunized without adjuvant. CD80/CD86 double knockout mice showed the most severe defects in their antibody responses.
34. Schweitzer AN, Borriello F, Wong RCK, Abbas AK, Sharpe AH: •• Role of costimulators in T cell differentiation. J Immunol 1997, 158:2713-2722. Cytokine profiles of T cells stimulated by splenic APCs from CD80 or CD86 knockout mice were investigated. Both IL-4 and IFN-γ production were significantly reduced in T cells stimulated by CD86-negative APCs.